Filing Details
- Accession Number:
- 0001161697-22-000560
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-23 17:00:19
- Reporting Period:
- 2022-11-21
- Accepted Time:
- 2022-11-23 17:00:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1109775 | H Philip Coelho | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-21 | 70,000 | $15.23 | 179,553 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-22 | 20,001 | $17.30 | 159,552 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2022-11-23 | 9,999 | $17.45 | 149,553 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. Coelho remains a director of the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.01 to $15.59 per share.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.28 to $17.335 per share.
Billionaire Hedge Funds
